Cargando…
Risk Factor Control Five Years after Coronary Bypass Grafting
The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a sin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Physicians of London
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401540/ https://www.ncbi.nlm.nih.gov/pubmed/8709060 |
_version_ | 1783231072305152000 |
---|---|
author | Skinner, J S Farrer, M Albers, C J Adams, P C |
author_facet | Skinner, J S Farrer, M Albers, C J Adams, P C |
author_sort | Skinner, J S |
collection | PubMed |
description | The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a single centre. Five years after surgery 309 patients were alive without further cardiac surgery, questionnaire follow-up was available in 291 (94%). Lipid profile measurements were made in 255 (83%) of these five-year survivors and 100 (34%) had a history of hypertension. Five years after surgery, 146 (50%) of the 291 patients thought they had high cholesterol, of whom 92 (63%) were following a diet, 36 (25%) were also taking lipid-lowering drugs and 18 (12%) were taking no measures; 141 (48%) of them did not think they had high cholesterol, and four (2%) did not know. There had been a favourable change in all lipid fractions compared with pre-operation, including total serum cholesterol, particularly in patients taking lipid-lowering drugs. However, total serum cholesterol was above 5.2 mmol/l in 203 (80%) patients and low-density lipoprotein (LDL) cholesterol was above 3.4 mmol/l in 180 (71%). Only 30% of patients taking lipid-lowering drugs had an LDL cholesterol of 3.4 mmol/l or less. Blood pressure was recorded in 257 (83%) of the 309 five-year survivors: 82 (28%) were taking antihypertensive medication; 32 (12%) and 87 (34%) patients had a diastolic blood pressure above 95 mmHg and 90 mmHg, respectively, and 49 (19%) had a systolic blood pressure above 160 mmHg. There were 22 (9%) regular cigarette smokers. Corroboration of non-smoking with exhaled carbon monoxide measurements confirmed an accurate history of non-smoking in nearly all patients. |
format | Online Article Text |
id | pubmed-5401540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Royal College of Physicians of London |
record_format | MEDLINE/PubMed |
spelling | pubmed-54015402019-01-22 Risk Factor Control Five Years after Coronary Bypass Grafting Skinner, J S Farrer, M Albers, C J Adams, P C J R Coll Physicians Lond Original Papers The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a single centre. Five years after surgery 309 patients were alive without further cardiac surgery, questionnaire follow-up was available in 291 (94%). Lipid profile measurements were made in 255 (83%) of these five-year survivors and 100 (34%) had a history of hypertension. Five years after surgery, 146 (50%) of the 291 patients thought they had high cholesterol, of whom 92 (63%) were following a diet, 36 (25%) were also taking lipid-lowering drugs and 18 (12%) were taking no measures; 141 (48%) of them did not think they had high cholesterol, and four (2%) did not know. There had been a favourable change in all lipid fractions compared with pre-operation, including total serum cholesterol, particularly in patients taking lipid-lowering drugs. However, total serum cholesterol was above 5.2 mmol/l in 203 (80%) patients and low-density lipoprotein (LDL) cholesterol was above 3.4 mmol/l in 180 (71%). Only 30% of patients taking lipid-lowering drugs had an LDL cholesterol of 3.4 mmol/l or less. Blood pressure was recorded in 257 (83%) of the 309 five-year survivors: 82 (28%) were taking antihypertensive medication; 32 (12%) and 87 (34%) patients had a diastolic blood pressure above 95 mmHg and 90 mmHg, respectively, and 49 (19%) had a systolic blood pressure above 160 mmHg. There were 22 (9%) regular cigarette smokers. Corroboration of non-smoking with exhaled carbon monoxide measurements confirmed an accurate history of non-smoking in nearly all patients. Royal College of Physicians of London 1996 /pmc/articles/PMC5401540/ /pubmed/8709060 Text en © Journal of the Royal College of Physicians of London 1996 http://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits non-commercial use and redistribution provided that the original author and source are credited. |
spellingShingle | Original Papers Skinner, J S Farrer, M Albers, C J Adams, P C Risk Factor Control Five Years after Coronary Bypass Grafting |
title | Risk Factor Control Five Years after Coronary Bypass Grafting |
title_full | Risk Factor Control Five Years after Coronary Bypass Grafting |
title_fullStr | Risk Factor Control Five Years after Coronary Bypass Grafting |
title_full_unstemmed | Risk Factor Control Five Years after Coronary Bypass Grafting |
title_short | Risk Factor Control Five Years after Coronary Bypass Grafting |
title_sort | risk factor control five years after coronary bypass grafting |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401540/ https://www.ncbi.nlm.nih.gov/pubmed/8709060 |
work_keys_str_mv | AT skinnerjs riskfactorcontrolfiveyearsaftercoronarybypassgrafting AT farrerm riskfactorcontrolfiveyearsaftercoronarybypassgrafting AT alberscj riskfactorcontrolfiveyearsaftercoronarybypassgrafting AT adamspc riskfactorcontrolfiveyearsaftercoronarybypassgrafting |